Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

Interleukin-10-deficient mice develop chronic enterocolitis

1993 • 4,225 citations

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

1992 • 1,259 citations

Chronic Lymphocytic Leukemia

1995 • 799 citations

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.

1994 • 543 citations

Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10

1992 • 525 citations

Polygenic control of susceptibility to murine systemic lupus erythematosus

1994 • 484 citations

Lupus susceptibility loci in New Zealand mice.

1994 • 359 citations

Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10 [see comments]

1992 • 247 citations

Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals.

1988 • 172 citations

Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma [see comments]

1995 • 156 citations

Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells

1995 • 155 citations

Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.

1995 • 146 citations

Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.

1993 • 145 citations

Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.

1993 • 138 citations

Genetic studies in NZB mice. V. Recombinant inbred lines demonstrate that separate genes control autoimmune phenotype.

1981 • 116 citations

Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.

1995 • 102 citations

Genetic studies in NZB mice. I. Spontaneous autoantibody production.

1978 • 94 citations

The NZB mouse as a model for chronic lymphocytic leukemia.

1992 • 86 citations

Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT.

1995 • 75 citations

Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. Tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response.

1995 • 64 citations

BSAP: a key regulator of B-cell development and differentiation

1995 • 55 citations

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]

1995 • 52 citations

Genetic studies in NZB mice

1979 • 49 citations

Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide

1995 • 41 citations

Interleukin‐10 mRNA expression in B‐cell chronic lymphocytic leukaemia inversely correlates with progression of disease

1996 • 40 citations

A cultured malignant B-1 line serves as a model for Richter's syndrome.

1994 • 35 citations

Expression of interleukin 10 in B lymphocytes of different origin.

1993 • 33 citations

H‐2^Z Homozygous New Zealand Mice as a Model for B‐Cell Chronic Lymphocytic Leukemia: Elevated bcl‐2 Expression in CD5 B Cells at Premalignant and Malignant Stages

1993 • 20 citations

Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia.

1995 • 12 citations

Regulatory aspects of clonally expanded B-1 (CD5+B) cells

1992 • 10 citations

REGULATION OF CLL BY INTERLEUKIN-10 - ROLE OF ANTISENSE IL-10

1995 • 9 citations

Large‐Cell “Mixed‐Phenotype” Lymphoma in AIDS

1992 • 7 citations

Altered calcium signal transduction in B‐1 malignant cells

1995 • 5 citations

V_H Gene Use by CD5+ AIDS‐Associated B‐Cell Lymphoproliferations

1995 • 3 citations